Straits Times Index
3,302.51 -11.54 (-0.35%) Nikkei
39,135.91 +66.23 (+0.17%) Hang Seng
19,208.27 -427.95 (-2.18%) FTSE 100
8,424.20 +3.94 (+0.05%) Bitcoin USD
71,257.18 +4,555.55 (+6.83%) CMC Crypto 200
1,515.25 +160.84 (+11.88%)
NanoVibronix, Inc. (NAOV)
After hours:
- Business Wire
NanoVibronix Issues Letter to Stockholders
TYLER, Texas, May 16, 2024--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today issued a letter to its stockholders from its Chief Executive Officer, Brian Murphy, providing a review of the first quarter of 2024 and recent business developments.
- Business Wire
NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield
TYLER, Texas, May 14, 2024--NanoVibronix, Inc. (Nasdaq: NAOV) ("NanoVibronix," or the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into a distribution agreement with CB Medical, LLC ("CB Medical") for the sale and distribution of the Company’s UroShield.
- Business Wire
NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award
ELMSFORD, N.Y., May 01, 2024--NanoVibronix, Inc. (Nasdaq: NAOV) ("NanoVibronix," or the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that effective May 1, 2024, the Company’s PainShield product will be included in the U.S. Department of Veteran Affairs’ ("VA") Federal Supply Schedule ("FSS"), a program that supports the healthcare acquisition needs of the VA and
